SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-014838
Filing Date
2022-03-24
Accepted
2022-03-24 16:01:00
Documents
14
Period of Report
2022-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea157245-8k_inmunebio.htm   iXBRL 8-K 28572
2 FORM OF OPTION AGREEMENT BETWEEN THE COMPANY AND NON-EMPLOYEE DIRECTORS AND CONS ea157245ex10-1_inmunebio.htm EX-10.1 32797
3 FORM OF OPTION AGREEMENT FOR EMPLOYEES OF THE COMPANY ea157245ex10-2_inmunebio.htm EX-10.2 47130
  Complete submission text file 0001213900-22-014838.txt   303368

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inmb-20220321.xsd EX-101.SCH 3036
5 XBRL LABEL FILE inmb-20220321_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE inmb-20220321_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT ea157245-8k_inmunebio_htm.xml XML 3710
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 22766443
SIC: 2836 Biological Products, (No Diagnostic Substances)